HIIFS
HZNP

Harel Insurance Investments & Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-770
Closed -$14K – 471
2016
Q3 		$14K Hold
770
– – ﹤0.01% 357
2016
Q2 		$13K Buy
770
+300
+64% +$4.85K ﹤0.01% 536
2016
Q1 		$8K Sell
470
-105
-18% -$1.84K ﹤0.01% 381
2015
Q4 		$12K Buy
+575
New +$11.2K ﹤0.01% 293

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harel Insurance Investments & Financial Services's HZNP Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2016, closing a stake of 770 shares — an estimated $14K sold.

Harel Insurance Investments & Financial Services first reported a position in HZNP in Q4 2015 and held it in 4 quarters. The position peaked at $14K in Q3 2016. 234 funds tracked by Wall St. Rank hold HZNP as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 770 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2016, an estimated $14K.
  • Harel Insurance Investments & Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $14K in Q3 2016.
  • 234 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.